Pancreatic Cancer Research

ResearcherUniversity Hospital FrankfurtNo recent work listed

Lothar Bergmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4377-8248; OpenAlex author ID A5068927061. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: none · 2014: none · 2015: 1 paper

Papers 5

  1. A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European… Co-author DOI 10.1016/j.ejca.2014.10.010↗
  2. Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group). Co-author DOI 10.1007/s10637-011-9665-x↗
  3. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines. Last author DOI 10.1007/s13277-011-0290-2↗
  4. Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines. Last author DOI 10.1007/s13277-010-0143-4↗
  5. Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression. Last author DOI 10.1097/mpa.0b013e318204ea7b↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wolfgang Glienke · 3 shared papers, 2011–2012 · strength 0.13
  2. Max Ernst Scheulen · 2 shared papers, 2012–2015 · strength 0.07
  3. Heike Richly · 1 shared paper, 2015 · strength 0.04
  4. Bernhard Josef Wormann · 1 shared paper, 2015 · strength 0.04
  5. Beate S. Schultheis · 1 shared paper, 2012 · strength 0.03
  6. Dirk Strumberg · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.